Skip to main content
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Care
Discover
Teach
Rubin Lab
Explore this Website
Home
News
About Us
Research
Lab Team
Publications
Resources
Toggle Resources menu options
FISH
Profiler
Tracking Samples
Weill Cornell Medicine
Care
Discover
Teach
Home
News
About Us
Research
Lab Team
Publications
Resources
Home
Publications
Publications
Found 11 results
Author
Title
Type
Year
Filters:
First Letter Of Last Name
is
M
[Clear All Filters]
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
M
Mu P
,
Zhang Z
,
Benelli M
,
Karthaus WR
,
Hoover E
,
Chen C-C
,
Wongvipat J
,
Ku S-Y
,
Gao D
,
Cao Z
et al.
. 2017.
SOX2 promotes lineage plasticity and antiandrogen resistance in TP53- and RB1-deficient prostate cancer.
.
Science. 355(6320):84-88.
Mosquera J-M
,
Varma S
,
Pauli C
,
MacDonald TY
,
Yashinskie JJ
,
Varga Z
,
Sboner A
,
Moch H
,
Rubin MA
,
Shin SJ
. 2015.
MAGI3-AKT3 fusion in breast cancer amended.
.
Nature. 520(7547):E11-2.
Mosquera J-M
,
Perner S
,
Genega EM
,
Sanda M
,
Hofer MD
,
Mertz KD
,
Paris PL
,
Simko J
,
Bismar TA
,
Ayala G
et al.
. 2008.
Characterization of TMPRSS2-ERG fusion high-grade prostatic intraepithelial neoplasia and potential clinical implications.
.
Clin Cancer Res. 14(11):3380-5.
Mosquera J-M
,
Perner S
,
Demichelis F
,
Kim R
,
Hofer MD
,
Mertz KD
,
Paris PL
,
Simko J
,
Collins C
,
Bismar TA
et al.
. 2007.
Morphological features of TMPRSS2-ERG gene fusion prostate cancer.
.
J Pathol. 212(1):91-101.
Mosquera J-M
,
Mehra R
,
Regan MM
,
Perner S
,
Genega EM
,
Bueti G
,
Shah RB
,
Gaston S
,
Tomlins SA
,
Wei JT
et al.
. 2009.
Prevalence of TMPRSS2-ERG fusion prostate cancer among men undergoing prostate biopsy in the United States.
.
Clin Cancer Res. 15(14):4706-11.
Mosquera JMiguel
,
Beltran H
,
Park K
,
MacDonald TY
,
Robinson BD
,
Tagawa ST
,
Perner S
,
Bismar TA
,
Erbersdobler A
,
Dhir, iv R
et al.
. 2013.
Concurrent AURKA and MYCN gene amplifications are harbingers of lethal treatment-related neuroendocrine prostate cancer.
.
Neoplasia. 15(1):1-10.
Mertz KD
,
Demichelis F
,
Sboner A
,
Hirsch MS
,
Dal Cin P
,
Struckmann K
,
Storz M
,
Scherrer S
,
Schmid DM
,
Strebel RT
et al.
. 2008.
Association of cytokeratin 7 and 19 expression with genomic stability and favorable prognosis in clear cell renal cell cancer.
.
Int J Cancer. 123(3):569-76.
Mertz KD
,
Setlur SR
,
Dhanasekaran SM
,
Demichelis F
,
Perner S
,
Tomlins S
,
Tchinda J
,
Laxman B
,
Vessella RL
,
Beroukhim R
et al.
. 2007.
Molecular characterization of TMPRSS2-ERG gene fusion in the NCI-H660 prostate cancer cell line: a new perspective for an old model.
.
Neoplasia. 9(3):200-6.
Mertz KD
,
Demichelis F
,
Kim R
,
Schraml P
,
Storz M
,
Diener P-A
,
Moch H
,
Rubin MA
. 2007.
Automated immunofluorescence analysis defines microvessel area as a prognostic parameter in clear cell renal cell cancer.
.
Hum Pathol. 38(10):1454-62.
Mateo J
,
Boysen G
,
Barbieri CE
,
Bryant HE
,
Castro E
,
Nelson PS
,
Olmos D
,
Pritchard CC
,
Rubin MA
,
de Bono JS
. 2016.
DNA Repair in Prostate Cancer: Biology and Clinical Implications.
.
Eur Urol.
Mateo J
,
Carreira S
,
Sandhu S
,
Miranda S
,
Mossop H
,
Perez-Lopez R
,
Rodrigues DNava
,
Robinson D
,
Omlin A
,
Tunariu N
et al.
. 2015.
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer.
.
N Engl J Med. 373(18):1697-708.